Factors affecting employment in Japanese patients with ankylosing spondylitis (AS) [PDF]
BMC RheumatologyBackground Ankylosing spondylitis (AS) often affects individuals during their most productive working years. However, few studies have investigated factors influencing employment in Japanese AS patients.
Hoshiko Furusawa +6 more
doaj +2 more sources
Spine Fractures of Patients with Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis: Fracture Severity and Injury-Related Mortality at a Level I Trauma Center [PDF]
Asian Spine Journal, 2023 Study Design Retrospective review of prospectively collected cohort. Purpose To identify differences in treatment and mortality of spine fractures in patients with ankylosing conditions of the spine. Overview of Literature Ankylosing spondylitis (AS) and
Stephen Ryan Chen +9 more
doaj +1 more source
Primary Biliary Cholangitis with Ankylosing Spondylitis
The Korean Journal of Gastroenterology, 2022 Primary biliary cholangitis is a chronic inflammatory autoimmune liver disease that is characterized by a positive antimitochondrial antibodies test and progressive destruction of the small intrahepatic bile duct.
Young Mi Hong, Ki Tae Yoon, Mong Cho
doaj +1 more source
Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis [PDF]
, 2009 OBJECTIVES:\ud To assess, quantify and summarise the cost of illness of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) from the societal perspective.\ud \ud METHODS:\ud Original studies reporting costs of RA or AS were searched systematically.
Ament, A.J.H.A. +4 more
core +20 more sources
Clinical Case Reports, 2023 Key Clinical Message Clinicians should be aware of rare manifestations of AS, while considering a low threshold for screening vascular involvement in an axial SpA/nrxSpA/AS presenting with unexplained fevers and significant constitutional symptoms and ...
Mahsa Mehdipour Dalivand +6 more
doaj +1 more source
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). [PDF]
, 2020 OBJECTIVES: To investigate the efficacy and safety of ixekizumab for up to 52 weeks in two phase 3 studies of patients with active radiographic axial spondyloarthritis (r-axSpA) who were biological disease-modifying antirheumatic drug (bDMARD)-naive ...
Baraliakos, X. +19 more
core +3 more sources
Egyptian Rheumatology and Rehabilitation, 2021 Background Ankylosing spondylitis (AS) is an autoimmune multisystemic disease that attacks the spine, sacroiliacs, and often causes asymmetrical peripheral oligoarthritis. It results from the interaction between the genetic factors mainly Human Leukocyte
Hanan M. Farouk +2 more
doaj +1 more source
Ankylosing spondylitis: how does it affect the quality of life?
Liječnički vjesnik, 2023 Ankylosing spondylitis is a progressive and debilitating disease known to immensely affect the quality of life and frequently cause disability. There are several instruments that measure this effect, such as Bath Ankylosing Spondylitis Disease Activity ...
Eva Perak +3 more
doaj +1 more source
Disease and psychological status in ankylosing spondylitis. [PDF]
, 2006 Objectives. Psychological factors may be important in the assessment and management of ankylosing spondylitis (AS). Our primary objective was to describe associations between disease and psychological status in AS, using AS-specific assessment tools and ...
Goodacre, J. A. +5 more
core +1 more source
Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis
Современная ревматология, 2011 The paper describes the pathomorphological aspects of ankylosing spondylitis (AS) and the value of nonsteroidal anti-inflammatory drugs in its therapy. Clinical trials demonstrate the high efficacy of aceclofenac (aertal) in AS.
A A Godzenko
doaj +1 more source